title: Gauging the Long-Term Benefits of Ipilimumab in Melanoma.
authors: University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, CA aribas@mednet.ucla.edu.
authors: Antoni
authors: A
authors: Ribas
authors: Massachusetts General Hospital Cancer Center, Boston, MA.
authors: Keith T
authors: KT
authors: Flaherty
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents